Globus Medical, Inc. (GMED)
NYSE: GMED · IEX Real-Time Price · USD
68.05
+0.13 (0.19%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Globus Medical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2010
Cash & Equivalents
467.29150.47193.07239.4195.72
Upgrade
Short-Term Investments
50.5295.59250.38187.34115.76
Upgrade
Cash & Cash Equivalents
517.79446.06443.45426.74311.49
Upgrade
Cash Growth
16.08%0.59%3.91%37.00%-8.30%
Upgrade
Receivables
503.24213.25164.44141.68154.33
Upgrade
Inventory
848.14298.98237229.15196.31
Upgrade
Other Current Assets
46.2225.0619.6324.225.34
Upgrade
Total Current Assets
1,915983.34864.52821.77687.47
Upgrade
Property, Plant & Equipment
646.86249.72221.08216.88199.84
Upgrade
Long-Term Investments
75.43495.85562.48358.52409.51
Upgrade
Goodwill and Intangibles
2,359261.05248.37243.67207.59
Upgrade
Other Long-Term Assets
89.2886.1760.8338.6527.67
Upgrade
Total Long-Term Assets
3,1711,0931,093857.72844.61
Upgrade
Total Assets
5,0862,0761,9571,6791,532
Upgrade
Accounts Payable
56.6736.124.1627.4634.93
Upgrade
Deferred Revenue
18.3714.112.038.135.4
Upgrade
Current Debt
11.972.54000
Upgrade
Other Current Liabilities
305.34106.47103.9885.2171.07
Upgrade
Total Current Liabilities
392.35159.2140.16120.79111.4
Upgrade
Long-Term Debt
508.443.48000
Upgrade
Other Long-Term Liabilities
187.3467.0775.7152.418.22
Upgrade
Total Long-Term Liabilities
695.7870.5575.7152.418.22
Upgrade
Total Liabilities
1,088229.75215.88173.19129.63
Upgrade
Total Debt
520.46.01000
Upgrade
Debt Growth
8557.53%----
Upgrade
Retained Earnings
1,1371,2401,1941,0451,048
Upgrade
Comprehensive Income
-10.19-24.63-6.773.96-2.9
Upgrade
Shareholders' Equity
3,9981,8461,7411,5061,402
Upgrade
Net Cash / Debt
-2.62440.05443.45426.74311.49
Upgrade
Net Cash / Debt Growth
--0.77%3.91%37.00%-8.30%
Upgrade
Net Cash Per Share
-0.024.294.284.233.05
Upgrade
Working Capital
1,523824.14724.35700.97576.07
Upgrade
Book Value Per Share
35.3518.3817.2915.2814.14
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).